Applied Nutrition and Food Chemistry, Lund University
Lund, SE-221 00, Sweden
NCT Number: NCT01718418
The purpose of the study is to evaluate food factors related to colonically derived regulation of glucose metabolism (and related parameters) and satiety using a semi-acute meal study in healthy subjects as experimental model.
Looking for future studies?
Notify Me20 year–35 year
All sexes
Interventional
Early Phase 1
Lund, SE-221 00, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Post-prandially after breakfast, 0-210 min
Variables (blood glucose, insulin, incretin, inflammatory markers, markers of colonic fermentation) are measured after two-weeks ingestion of test products. The experimental day is terminated after a lunch meal.
Time frame: Post-prandially after breakfast, 0-210 min
Energy intake at lunch is measured after two-weeks ingestion of test products. The experimental day is terminated after the lunch meal.
Time frame: post-prandially after breakfast, 0-210 min
The subjective sensation of satiety, hunger and desire to eat is measured using a (VAS) questionnaire.
Time frame: Faecal samples are collected after 14 days intake of test- and reference product
The effect on gut microbiota of 14 days intake of test- and reference product are investigated in faecal samples.
Lund University
Other
Prebiotics and Probiotics as Means to Modulate Colonic Events, With Specific Focus on Metabolism and Satiety
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT07204483
Behavior, Behavioral Symptoms
Naha, Okinawa, Japan
View Trial DetailsNCT06501001
Behavior, Body Weight
Toledo, Spain
View Trial Details